Endoscopic Submucosal Dissection for Early Colorectal Carcinoma with High-risk Criteria: Long-term Follow-up from the German Multicenter Registry
Abstract Background and Study Aim Endoscopic submucosal dissection (ESD) is recommended for selected colorectal lesions, especially those with superficial submucosal invasion, enabling en-bloc resection and accurate histopathologic assessment. However, the management of high-risk lesions following ESD, especially regarding additional surgery versus surveillance, remains debated. This study evaluated outcomes after ESD for pT1 colorectal carcinoma, comparing surgical versus conservative management. Patients/Materials and Methods This retrospective multicenter study included 92 patients with pT1 colorectal carcinoma treated by ESD at 14 German referral centers (January 2017–December 2020). Patients were classified as low-risk (n = 34) or high-risk (n = 58) based on histopathologic criteria. Long-term outcomes were compared between low- and high-risk patients, as well as between high-risk patients undergoing additional surgery versus conservative management. Results The overall three-year disease-free survival was 82.6%, without a significant difference between the low-risk (88.2%) and high-risk groups (79.3%; p = 0.276). Among high-risk patients, 56.9% received additional surgery and 43.1% were managed conservatively. Recurrences occurred exclusively in the high-risk group (5.2%). The R0 resection rate after ESD was higher in patients managed without additional surgery than in those who subsequently underwent surgery (76.0% vs. 45.5%; p = 0.019). Conclusion ESD is effective for curative management of selected early colorectal cancers (pT1), particularly in low-risk cases. In high-risk patients, surgery remains the standard, with no recurrences observed after additional surgery in our cohort. A substantial proportion of high-risk patients did not undergo surgery in clinical practice and showed a recurrence rate of 12% (3/25). These findings support current recommendations while reflecting real-world treatment patterns.
Authors
- Andreas Wannhoff (ORCID: https://orcid.org/0000-0002-9660-1323)
- Anna Muzalyova (ORCID: https://orcid.org/0000-0003-4441-8006)
- Jürgen Pohl
- Andreas Probst (ORCID: https://orcid.org/0000-0002-1486-9298)
- Alanna Ebigbo (ORCID: https://orcid.org/0000-0001-7765-035X)
- Ingo Steinbrück (ORCID: https://orcid.org/0000-0001-9056-8844)
- Jörg Schirra
- M Anzinger
- Stefan Sulk
- Dani Dakkak
- Franz Ludwig Dumoulin (ORCID: https://orcid.org/0000-0002-1058-7867)
- Siegbert Faiss (ORCID: https://orcid.org/0000-0002-9920-3582)
- Ulrike Denzer
- Sara Moser (ORCID: https://orcid.org/0009-0005-4024-635X)
- Roland Reinehr
- Hans-Peter Allgaier
- Viktor Rempel
- Carola Fleischmann
- Helmut Messmann
Institutions
- Philipps University of Marburg (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- University Hospital Augsburg (DE)
- Asklepios Klinik Altona (DE)
- Elisabeth-Krankenhaus Essen (DE)
- Sana Klinikum Lichtenberg (DE)
- Nuremberg Hospital (DE)
- St. Josefs Hospital (DE)
- Krankenhaus Barmherzige Brüder (DE)
- Gemeinschaftskrankenhaus Havelhöhe (DE)
- Elbe Kliniken Stade-Buxtehude (DE)
- St. Josef-Hospital (DE)
- Evangelisches Diakoniekrankenhaus (DE)
- Klinikum Ludwigsburg (DE)
- Asklepios Klinik Barmbek (DE)
- St. Anna Hospital (DE)
- University Hospital Carl Gustav Carus (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Endoscopy International Open
- Published
- 2026-09-18
- DOI
- https://doi.org/10.1055/a-2949-2685
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00